NANOVIRICIDES, INC. Quarterly Nonoperating Income (Expense) in USD from Q3 2010 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Nanoviricides, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q3 2010 to Q4 2024.
  • Nanoviricides, Inc. Nonoperating Income (Expense) for the quarter ending December 31, 2024 was $31.6K, a 54.8% decline year-over-year.
  • Nanoviricides, Inc. Nonoperating Income (Expense) for the twelve months ending December 31, 2024 was $162K, a 53.3% decline year-over-year.
  • Nanoviricides, Inc. annual Nonoperating Income (Expense) for 2024 was $222K, a 37.5% decline from 2023.
  • Nanoviricides, Inc. annual Nonoperating Income (Expense) for 2023 was $355K, a 5169% increase from 2022.
  • Nanoviricides, Inc. annual Nonoperating Income (Expense) for 2022 was $6.74K.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2024 $162K $31.6K -$38.3K -54.8% Oct 1, 2024 Dec 31, 2024 10-Q 2025-02-14
Q3 2024 $200K $41K -$21.8K -34.7% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-14
Q2 2024 $222K $35.4K -$71K -66.7% Apr 1, 2024 Jun 30, 2024 10-K 2024-09-27
Q1 2024 $293K $53.9K -$54K -50% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 $347K $69.8K -$19K -21.4% Oct 1, 2023 Dec 31, 2023 10-Q 2025-02-14
Q3 2023 $366K $62.8K +$11.1K +21.5% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 $355K $106K +$93.6K +732% Apr 1, 2023 Jun 30, 2023 10-K 2024-09-27
Q1 2023 $261K $108K +$113K Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 $149K $88.9K +$89.4K Oct 1, 2022 Dec 31, 2022 10-Q 2024-02-14
Q3 2022 $59.2K $51.7K +$52.4K Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 $6.74K $12.8K +$11.4K +817% Apr 1, 2022 Jun 30, 2022 10-K 2023-10-13
Q1 2022 -$4.66K -$4.79K -$4.29K -867% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 -$362 -$558 +$37.6K +98.5% Oct 1, 2021 Dec 31, 2021 10-Q 2023-02-14
Q3 2021 -$37.9K -$703 +$40.1K +98.3% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$78.1K $1.39K +$44.2K Apr 1, 2021 Jun 30, 2021 10-K 2022-10-13
Q1 2021 -$122K -$495 +$5.54M +100% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 -$5.66M -$38.1K +$255K +87% Oct 1, 2020 Dec 31, 2020 10-Q 2022-02-14
Q3 2020 -$5.92M -$40.9K -$468K -110% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 -$5.45M -$42.8K +$868 +1.99% Apr 1, 2020 Jun 30, 2020 10-K 2021-10-12
Q1 2020 -$5.45M -$5.54M -$5.48M -9631% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-14
Q4 2019 $33.1K -$293K -$431K -312% Oct 1, 2019 Dec 31, 2019 10-Q 2021-02-16
Q3 2019 $464K $427K +$229K +116% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-16
Q2 2019 $235K -$43.7K -$675K -107% Apr 1, 2019 Jun 30, 2019 10-K 2021-10-12
Q1 2019 $911K -$56.9K -$365K -118% Jan 1, 2019 Mar 31, 2019 10-Q 2020-06-22
Q4 2018 $1.28M $138K +$541K Oct 1, 2018 Dec 31, 2018 10-Q 2020-02-14
Q3 2018 $734K $198K -$27.3K -12.1% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-15
Q2 2018 $762K $632K +$943K Apr 1, 2018 Jun 30, 2018 10-K 2020-10-13
Q1 2018 -$181K $308K +$831K Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-15
Q4 2017 -$1.01M -$403K -$1.15M -154% Oct 1, 2017 Dec 31, 2017 10-Q 2019-02-14
Q3 2017 $142K $225K +$846K Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 -$704K -$311K -$1.16M -137% Apr 1, 2017 Jun 30, 2017 10-K 2019-08-23
Q1 2017 $452K -$523K +$2.42M +82.2% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-21
Q4 2016 -$1.97M $751K +$1.44M Oct 1, 2016 Dec 31, 2016 10-Q 2018-02-20
Q3 2016 -$3.4M -$621K -$1.54M -168% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-14
Q2 2016 -$1.87M $845K -$787K -48.2% Apr 1, 2016 Jun 30, 2016 10-K 2018-10-12
Q1 2016 -$1.08M -$2.94M -$3.82M -438% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-15
Q4 2015 $2.74M -$685K -$508K -286% Oct 1, 2015 Dec 31, 2015 10-Q 2017-02-14
Q3 2015 $3.24M $918K -$1.62M -63.8% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-14
Q2 2015 $4.86M $1.63M +$4.84M Apr 1, 2015 Jun 30, 2015 10-K 2017-09-28
Q1 2015 $26.6K $872K -$1.69M -65.9% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-10
Q4 2014 $1.71M -$177K -$565K -146% Oct 1, 2014 Dec 31, 2014 10-Q 2016-02-09
Q3 2014 $2.28M $2.54M +$7.21M Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-09
Q2 2014 -$4.93M -$3.21M -$2.59M -421% Apr 1, 2014 Jun 30, 2014 10-K 2016-09-16
Q1 2014 -$2.34M $2.56M +$4.05M Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-15
Q4 2013 -$6.39M $388K +$353K +1001% Oct 1, 2013 Dec 31, 2013 10-Q/A 2015-02-25
Q3 2013 -$6.75M -$4.67M -$4.46M -2094% Jul 1, 2013 Sep 30, 2013 10-Q/A 2015-02-23
Q2 2013 -$2.29M -$616K -$499K -428% Apr 1, 2013 Jun 30, 2013 10-K/A 2013-10-08
Q1 2013 -$1.79M -$1.49M -$1.54M -3421% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-15
Q4 2012 -$249K $35.2K +$89.5K Oct 1, 2012 Dec 31, 2012 10-Q 2014-02-14
Q3 2012 -$339K -$213K -$213K -47217% Jul 1, 2012 Sep 30, 2012 10-Q/A 2013-11-18
Q2 2012 -$125K -$117K -$121K -3076% Apr 1, 2012 Jun 30, 2012 10-K/A 2015-02-23
Q1 2012 -$4.95K $44.9K +$34K +310% Jan 1, 2012 Mar 31, 2012 10-Q/A 2013-05-20
Q4 2011 -$38.9K -$54.3K +$22.2K +29% Oct 1, 2011 Dec 31, 2011 10-Q/A 2013-02-22
Q3 2011 -$61.1K $452 -$13.4K -96.7% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-19
Q2 2011 -$47.7K $3.92K Apr 1, 2011 Jun 30, 2011 10-K/A 2013-10-08
Q1 2011 $11K Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-21
Q4 2010 -$76.5K Oct 1, 2010 Dec 31, 2010 10-Q 2012-02-14
Q3 2010 $13.9K Jul 1, 2010 Sep 30, 2010 10-Q/A 2011-12-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.